InsidersTradesSigma
Total declarations
Company
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
10
Disclosed sells
0
T+90 hit rate
13%
T+90 mean return
-2.8%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Miller Richard A Md, Chief Executive Officer. Officer active across 1 company, notably Corvus Pharmaceuticals, Inc.. Aggregated, 12 reports have been published. Split: 10 buys · 0 sell. Total volume traded: €1.2m. Activity tracked since 4 May 2021. The latest transaction was filed on 7 May 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Miller Richard A Md
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
559,073 shares@ US$3.5057.9% of flowCommon StockSEC:0001610717-25-000115:0
302,016 shares0Common StockSEC:0001610717-24-000237:0
577,634 shares@ US$1.731231.1% of flowCommon StockSEC:0001610717-24-000231:0
Canonical exit: 4 Aug 2024 (T+90)
50,000 shares@ US$0.74031.2% of flowCommon StockSEC:0001567619-22-021650:0
Canonical exit: 13 Mar 2023 (T+90)
25,000 shares@ US$0.76280.7% of flowCommon StockSEC:0001567619-22-017917:0
Canonical exit: 27 Dec 2022 (T+90)
12,300 shares@ US$0.81010.3% of flowCommon StockSEC:0001567619-22-017639:0
Canonical exit: 19 Dec 2022 (T+90)
5,000 shares@ US$1.030.0005% mcap1.9% of flowCommon StockSEC:0001567619-22-013465:0
Canonical exit: 22 Sept 2022 (T+90)
4,830 shares@ US$0.980.0004% mcap1.7% of flowCommon StockSEC:0001567619-22-012396:0
Canonical exit: 31 Aug 2022 (T+90)
15,000 shares@ US$1.63560.0021% mcap8.4% of flowCommon StockSEC:0001567619-22-007839:0
Canonical exit: 29 Jun 2022 (T+90)
25,000 shares@ US$1.4660.0032% mcap12.7% of flowCommon StockSEC:0001567619-22-007172:0
Canonical exit: 13 Jun 2022 (T+90)
10,000 shares@ US$1.92540.6% of flowCommon StockSEC:0001567619-21-016250:0
Canonical exit: 18 Nov 2021 (T+90)
35,714 shares@ US$2.802.9% of flowCommon StockSEC:0001567619-21-009124:0
Canonical exit: 2 Aug 2021 (T+90)
12 of 12 declarations
About Miller Richard A Md
MILLER RICHARD A MD serves as President and CEO at Corvus Pharmaceuticals, Inc. He is responsible for the strategic direction of the company and the management of its daily operations. Under his leadership, Corvus Pharmaceuticals is committed to developing innovative treatments for serious diseases. MILLER RICHARD A MD plays a crucial role in defining the company's vision and establishing strong relationships with investors and partners.
